Biomaxima (WAR:BMX) Total Stockholders Equity : zł46.36 Mil (As of Sep. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Biomaxima Total Stockholders Equity?

Biomaxima's Total Stockholders Equity for the quarter that ended in Sep. 2024 was zł46.36 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Biomaxima's Book Value per Share for the quarter that ended in Sep. 2024 was zł11.06. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Biomaxima's Debt-to-Equity for the quarter that ended in Sep. 2024 was 0.32.

Biomaxima Total Stockholders Equity Historical Data

The historical data trend for Biomaxima's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomaxima Total Stockholders Equity Chart

Biomaxima Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

16.42

19.89

29.19

52.46

46.97

Biomaxima Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Stockholders Equity	Get a 7-Day Free Trial															50.91	46.97	47.03	46.60	46.36

Biomaxima (WAR:BMX) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Biomaxima's Book Value per Share for the quarter that ended in Sep. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(46.356	-	0)	/	4.193
	=	11.06

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Biomaxima's Debt-to-Equity for the quarter that ended in Sep. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(8.525	+	6.114)	/	46.356
	=	0.32

Biomaxima Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Biomaxima's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Biomaxima Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biomaxima SA (WAR:BMX) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

5 Vetterow Street, Lublin, POL, 20-277

Website

https://www.biomaxima.com

BioMaxima SA is a Polish company operating in the market of laboratory diagnostics. It is a manufacturer of microbiological substrates as well as a wide range of reagents and diagnostic equipment. The company is also a distributor of products of recognized multinational diagnostic companies such as: Accelerate Diagnostics, Nova Biomedical, PHC Group, Technoclone, Kabe and Biolog.

Biomaxima Headlines

No Headlines